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PHOBIAS, OTHER PSYCHIATRIC
COMORBIDITIES AND CHRONIC MIGRAINE
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ABSTRACT - B a c k g round: Comorbidity of chronic migraine (CM) with psychiatric disorders, mostly anxiety
and mood disorders, is a well-recognized phenomenon. Phobias are one of the most common anxiety dis-
o rders in the general population. Phobias are more common in migraineurs than non-migraineurs. The
clinical profile of phobias in CM has never been studied. Method: We investigated the psychiatric pro-
file in 56 patients with CM using the SCID I/P interview. Results: Lifetime criteria for at least one mental
d i s o rder was found in 87.5% of the sample; 75% met criteria for at least one lifetime anxiety disorder and
60.7% of our sample fulfilled DSM-IV criteria for lifetime phobic avoidant disorders. Mood and anxiety
s c o res were higher in phobic patients than in non-phobic CM controls. Number of phobias correlated with
higher levels of anxiety and depre s s i o n . Conclusion: Phobias are common in CM. Its recognition may influ-
ence its management. Early treatment may lead to better prognosis.
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Fobias, outras comorbidades psiquiátricas e enxaqueca crônica
RESUMO - I n t rodução: As comorbidades psiquiátricas das enxaquecas crônicas são bem conhecidas. As
fobias, transtorno ansioso mais comum, são mais prevalentes entre enxaquecosos do que entre não enxa-
quecosos. O perfil clínico de fobias em uma população enxaquecosa nunca foi estudado. M é t o d o :
Estudamos aspectos psiquiátricos de uma população de 56 pacientes com enxaqueca crônica. R e s u l t a d o s :
Usando o SCID I/P para o DSM-IV, critérios diagnósticos para ao menos algum transtorno psiquiátrico durante
a vida foram preenchidos por 87,5% de nossa amostra, 75% para ao menos um transtorno ansioso e 60,7%
para condições fóbicas em algum momento de suas vidas. Os escores de ansiedade e humor foram maiore s
e n t re os fóbicos e o número de fobias teve correlação positiva com o grau de ansiedade e depre s s ã o .
Conclusão: Fobias são comuns na enxaqueca crônica e seu reconhecimento poderia influenciar seu mane-
jo e melhorar seu prognóstico.
PALAVRAS-CHAVE: cefaléia, enxaqueca, ansiedade, fobia. 
The importance of psychiatric comorbidity in
migraine has long been re c o g n i z e d1 , 2. There is a
g rowing body of evidences that they may share
diverse epidemiological, pathophysiology, and tre a t-
ment response aspects3. Among psychiatric comor-
bidities, those with mood and anxiety disorders are
the most common. Anxiety disorders are common in
episodic migraine patients but even more fre q u e n t
in chronic migraineurs4. Somatic complains are com-
mon among anxious subjects, mostly tachycardia, dys-
pnea, gastrointestinal discomfort, and muscular pain.
Headaches can also be part of these unspecific somat-
ic manifestations. On the other hand, migraine and
anxiety may be more closely related than just unspe-
cific somatic complains5 , 6. Merikangas et al.5, in a
p rospective study, found anxiety disorders to be more
f requently comorbid with migraine than aff e c t i v e
d i s o rders. They also suggest that migraine with anx-
iety and depression may constitute a distinct syn-
d rome comprising anxiety, the primary phenomena,
often manifested in early childhood, and followed
by the occurrence of migraine headaches, and then
by discrete episodes of depressive disorder in latter
adulthood. In other study, phobias in adolescents and
young adults were outstanding predictors of latter,
incident migraines7.
Anxiety disorders also greatly increase the use of
medical resources in migraine patients, with higher
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annual direct costs (12,642 US$ vs 5,179 US$)8 in the
United States of America. In addition, anxiety disor-
ders creates additional decreases in quality of life lev-
els in chronic migraine patients9. According to the
D S M - I V1 0, anxiety disorders encompass several con-
ditions including: generalized anxiety disorder (GAD),
panic disorder (PD) and agoraphobia, posttraumat-
ic stress disorder (PTSD), social phobia (SP), specific
phobia, obsessive-compulsive disorder (OCD) and the
less clearly defined mixed anxiety-depressive disor-
der. Phobias are the most common anxiety disorder
in the general population, the lifetime pre v a l e n c e
has been found to be up to 12.5% in specific pho-
bias and 13.0% in social phobia, which is one of the
most common psychiatric condition1 1 - 1 3; up to 23% if
child life simple phobias are included. Phobias are
m o re common in migraineurs than non-migraineurs;
the clinical profile of phobias in CM has never been
studied.
In this paper we re p o rton a systematic investiga-
tion on the clinical aspects of the comorbidity of pho-
bias in CM patients and their relationship with oth-
er psychiatric comorbidity.
METHOD
Fifty-six patients with CM according to the Intern a t i o n a l
Headache Society criteria (IHS)1 4 w e re selected for this study
(51 women, 5 men, aged 24 to 64 y. mean ±sd 41.69±1 1 . 7 1 ) .
C h ronic users of acute migraine medication that did not
fulfill criteria for medication overuse headache (MOE) were
also included in the study. Doubtful cases were excluded. 
Headache disability was measured by the Migraine
Disability Assessment (MIDAS)1 5, a 0 to 100 visual analogue
impact scale (0 meaning the highest impact and 100 no
impact) assessing the amount of disability caused by
headaches along the month (global) and during the attack.
Total headache frequency was also ascertained. 
Psychic profile was assessed by the SCID 1/P 1 6, a stru c-
t u red interview for psychiatric disorders based on the DSM-
IV diagnostic criteria1 0, and applied by a trained clinician.
We further evaluated intensity of depressive symptoms
with the Hamilton depression rating scale (HAM-D)1 7 a n d
the Beck depression inventory (BDI)1 8. The intensity of anx-
iety symptoms was assessed by the Hamilton rating scale
for anxiety (HAM-A)19 and the Spielberger state-trait anx-
iety inventory (STAI)20.
The re s e a rch protocol was reviewed and approved by
the Hospital Israelita Albert Einstein Committee of Ethic in
R e s e a rch. All subjects signed written consent form s prior
to assessment.
Statistical analyses were perf o rmed to investigate pos-
sible diff e rences in headache characteristics and in anxiety/
d e p ression scores in patients with phobias versus those
without phobias. The number of patients with a mood dis-
o rder (major depressive episode and/or dysthymia) was cal-
culated in those with and without phobias. The anxiety and
depression levels were also compared. 
The Fisher’s exact and the Student’s T-test were used
for the analysis. Results were considered significant when
P <.05 but trends of P <.10 were also re p o rted. All tests
w e re two tailed. Data were processed with the statistical
package SPSS 10.0 for windows (SPSS, Chicago, Illinois).
RESULTS
F o rty-nine patients (87.5%) of our sample met cri-
teria for at least one lifetime mental disord e r. Sixteen
subjects (28.6%) fulfilled criteria for major depre s-
sive disorder, one for dysthymia, 2 for bipolar disor-
der and 3 for grief. Two patients met criteria for an
eating disorder and 4 for alcohol and/or non-alco-
holic substance use disorders. Forty-two subjects
(75%) of our sample presented at least one lifetime
anxiety disord e r. Twenty-five subjects (44.6%) ful-
filled criteria for GAD, one for PD, one for OCD, and
3 cases for PTSD. The phobic conditions are fully
described in results.
T h i rty-four patients (60.7%) of our sample ful-
filled DSM-IV diagnostic criteria for a phobic anxious
condition (social, specific, or agoraphobia) in their
lifespan. At the moment of the evaluation, 20 (35.7%)
patients had a diagnosis of specific phobia, 15 (26.8%)
social phobia, and 2 agoraphobia. Four patients had
a history of phobic conditions in the past but did not
fulfilled criteria for these conditions at the moment
of the evaluation (one specific, one social and two
agoraphobia). Details upon prevalence, type and
severity of phobias are presented on Table 1. 
Interactions among phobias, mood disorders, and
non-phobic anxiety disorders, proved to be complex
Table 1. Detailed description of phobias according to specific
class and severity.
Class of phobia N (%) Severity N
Specific* 20 (58.8) Mild 9
Moderate 10
Severe 1
Social 15 (44.1) Mild 8
Moderate 8
Severe –




* Eight phobias of animal, nine of natural environment, five of injec-
tion, two of blood and two non-specified. Note - The values in the lines
“total” and “specific” are referred to the number of patients that ful-
fill criteria for at list one phobic diagnostic and at list one specific pho-
bia re s p e c t i v e l y. Notice that there may be some patients that have more
than one type of phobia.
with high levels of comorbidity. These interactions
can be well visualized in the Ve n n ’s diagram below
(Fig 1). 
When phobic patients are compared with non-
phobic patients, headache severity levels did not dif-
fer between the groups (Table 2) even though dif-
f e rences were found on severity of psychiatric symp-
toms (BDI, HAM-A and HAM-D or a trend in IDATE).
Some patients fulfilled criteria for more than one
kind of phobia, a variable that seem to exert influ-
ence on psychopathology as illustrated on Figure 2. 
DISCUSSION
Despite of the importance of phobic disorders and
the avoidant behaviour characteristic of phobic-anx-
ious conditions, among psychiatric comorbidities ob-
s e rved in migraneurs, very little was studied about
this issue. One study evaluated the personality of
patients with headaches, demonstrating that patients
with migraine and tension type headache score d
higher on harm avoidance factor of personality than
did contro l s2 1, even though this finding was not con-
f i rmed by other authors2 2. According to Cloninger’s
t h e o ry2 3, harm avoidance would be a heritable tem-
perament trait related to inhibition of behaviours,
such as pessimistic worry and passive avoidance
behaviours, such as fear of uncertainty and shyness.
Radat et al.24 pointed a greater incidence of psy-
chiatric disorders among migraneous patients that
c h ronically used substances compared with patients
without that history. In this study, two of the thre e
most frequent diagnosis observed were anxious con-
ditions and the other one was major depressive dis-
o rd e r, which was frequently accompanied by anxiety
symptoms, such as fear and avoidant behavior. In a
p rospective evaluation of this cohort, the authors
found important longitudinal comorbidity between
anxious disorders and migraine. However, in logistic
re g ression models including age, sex, and psychiatric
illness in 1981, only phobia was predictive of future
migraine7.
The present study provides more insight into the
understanding of a yet unexplored matter on migrai-
952 Arq Neuropsiquiatr 2006;64(4)
Table 2. Comparison of migraine severity and psychopathology between phobic and non-phobic patients. 
Migraine severity Psychopathology
Mean ±standard deviation Mean ±standard deviation
Phobic Non-phobic Phobic Non-phobic
Total frequency 25.93±5.01 26.38±4.85 STAI – trait** 46.70±9.80 42.00±9.52
MIDAS 69.03±69.30 92.50±90.45 STAI – state** 50.20±11.33 43.86±12.18
0–100 51.81±25.68 49.00±26.39 BDI* 15.13±9.22 9.95±7.36
Global impact 39.93±16.18 35.48±20.43 HAM-A* 18.97±6.86 15.14±6.36
HAM-D* 20.74±8.63 13.45±7.61
*p<05; **.05<p<.1
Fig 1. Venn diagram showing the interaction of psychiatric
comorbid disorders in chronic migraine patients. 
Fig 2. Mean psychiatric scales for patients with 0, 1, 2, or 3
p h o b i a s .
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ne field: the phobic-anxious aspects. A trend, a pho-
bic-anxious trait of personality, or a psychiatric (anx-
iety) disorder might play a role in the process of mi-
graine chronification. A comparison, for example, of
the rates of specific phobias in our sample (31.82%)
with the prevalence of phobias in the general pop-
ulation (12.5%)1 1 - 1 3, seems to show a trend of high-
er levels of phobias in CM then in the population as
a whole.
A preliminary understanding of this relationship
is provided by behavioral theories. A core feature of
phobic-avoidant disorders is the anticipatory anxi-
ety, a state of preparation for an imminent or likely
t h reat. Subjects with a high level of trait anxiety tend
to be more sensitive to potential threats or to the
aversive nature of anticipatory anxiety. These sub-
jects may develop avoidant behaviors to keep them
away from those stimuli or aversive emotional states.
This could explain, at least in part, why some patients
take hold of analgesics in the least warning of pain.
If so, we could be looking for a sub-group of CM pa-
tients with poorer prognosis, making their headaches
worse by overusing acute medication. Fear of hav-
ing a headache attack or worsening a baseline hea-
dache in daily suff e rers may start a behavior of anal-
gesic intake or decrease the threshold of analgesic
utilization25.
It must be clear, however, that definitive conclu-
sions about the role of phobias in favoring chronic-
ity and/or overuse could be drawn only by dire c t l y
comparing frequency of headache with the use of
acute migraine medication. In spite of the design of
the present study do not allow this direct conclusion,
we can observe that the more phobias patients pre s-
ent, the higher the levels of anxiety and depression
in CM patients. It has been recognized that they de-
s e rve special psychiatric attention, but a focus on
phobic aspects may influence its management and
eventually treatment response. Although there is a
lack of evidence to support any re c o m m e n d a t i o n s
when phobias and migraines are related, it is clear
that treating the phobic condition is a key point as
to avoid the overuse of analgesics. Psychological inter-
ventions may be outstanding on the maintenance of
the abstinence of analgesics. Treatment of phobias
in CM may lead to lower level of anxiety and depre s-
sion and a better quality of life.
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